A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
Clinical trial NCT06260267 · WITHDRAWN
Trial details
- NCT number
- NCT06260267
- Sponsor
- Ferring Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2026-01-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.